| ADR Ontology |
| ADR Term |
Progressive supranuclear palsy |
| ADR ID |
BADD_A07602 |
| ADR Hierarchy |
|
| Description |
A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7) [MeSH] |
| MedDRA Code |
10036813 |
| MeSH ID |
D013494; D013494; D013494
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Progressive supranuclear palsy | Steele-Richardson-Olszewski syndrome | Supranuclear Palsy, Progressive | Progressive Supranuclear Palsies | Supranuclear Palsies, Progressive | Palsy, Progressive Supranuclear | Progressive Supranuclear Ophthalmoplegia | Progressive Supranuclear Palsy | Steele-Richardson-Olszewski Disease | Steele Richardson Olszewski Disease | Steele-Richardson-Olszewski Syndrome | Steele Richardson Olszewski Syndrome | Syndrome, Steele-Richardson-Olszewski | Supranuclear Palsy, Progressive, 1 | Ophthalmoplegia, Progressive Supranuclear | Supranuclear Ophthalmoplegia, Progressive | Richardson's Syndrome | Richardson Syndrome | Syndrome, Richardson's |
|
|
| Drugs Leading to the ADR |
|
|
